Melatonin and Cetamide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Melatonin (melatonin) and Cetamide (sulfacetamide sodium). Common drug interactions include sensory loss among females and bronchitis among males.

The phase IV clinical study analyzes what interactions people have when they take Melatonin and Cetamide. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Melatonin?

Melatonin has active ingredients of melatonin. It is often used in insomnia. eHealthMe is studying from 56,212 Melatonin users. Check the latest studies of Melatonin.

What is Cetamide?

Cetamide has active ingredients of sulfacetamide sodium. eHealthMe is studying from 1,053 Cetamide users. Check the latest studies of Cetamide.

On Aug, 13, 2026

24 people who take Melatonin and Cetamide together, and have interactions are studied.

Melatonin and Cetamide drug interactions.

What are the common drug interactions of Melatonin and Cetamide, by gender? *:

female:

Sensory loss (senses loss)
Fatigue (feeling of tiredness)
Malignant melanoma (skin cancer rises from melancytes)
Anxiety
Balance disorder
Bladder disorder
Blood pressure increased
Diarrhoea
Dizziness
Dry mouth

male:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cough
Multiple allergies (allergy to multiple agents)
Nasopharyngitis (inflammation of the nasopharynx)
Arthralgia (joint pain)
Asthenia (weakness)
Bowel movement irregularity
Chest discomfort
Migraine (headache)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)

What are the common drug interactions of Melatonin and Cetamide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Glossitis (infection of tongue with soreness)
Pharyngeal erythema (pharyngeal redness)
Rash pruritic (redness with itching)
Tongue disorder (disease of tongue)

40-49:

Sensory loss (senses loss)
Malignant melanoma (skin cancer rises from melancytes)
Anxiety
Balance disorder
Bladder disorder
Dizziness
Dry mouth
Dysarthria (speech disorder)
Dysphagia (a condition in which swallowing is difficult or painful)
Fatigue (feeling of tiredness)

50-59:

Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)

60+:

Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Secretion discharge
Sinusitis (inflammation of sinus)
Arthralgia (joint pain)
Asthenia (weakness)
Bowel movement irregularity
Chest discomfort
Migraine (headache)
Musculoskeletal chest pain (pain in chest muscle or nerve or bones)

What are the existing conditions these people have? *

Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 7 people, 29.17%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 3 people, 12.50%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 8.33%
Gait Disturbance: 2 people, 8.33%
Depression: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Melatonin and Cetamide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously